Enliven Therapeutics
D

ELVN

41.500
USD
-0.49
(-1.17%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-25
حجم السوق
3,040,736,582

العنوان: Enliven Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.